Domain EYEION.com for sale! This premium domain is available now at Kadomain.com

APA calls for guardrails, education, to protect adolescent AI users

  • medicalxpress.com language
  • 2025-06-03 16:38 event
  • 2 months ago schedule
APA calls for guardrails, education, to protect adolescent AI users
The effects of artificial intelligence on adolescents are nuanced and complex, according to a report from the American Psychological Association that calls on developers to prioritize features that protect young people from exploitation, manipulation and the erosion of real-world relationships.

2.293. Focused intervention is a new way to reduce bias in family planning clinics

  • 2 months ago schedule
  • medicalxpress.com language

Millions of young women around the world face stigma and bias when seeking reproductive health services, often limiting their access to contraception and quality care. A new USC-led study conducted in over 200 clinics across Burkina Faso, Tanzania, and Pakistan shows that a focused intervention combining storytelling, peer support, and provider incentives can reduce this bias and expand contraceptive access for the young women who need it most.

2.294. Females may be more biochemically sensitive to alcohol long before dependence sets in

  • 2 months ago schedule
  • medicalxpress.com language

Alcohol affects everyone differently, but new research reveals that biological sex may play a bigger role than previously thought.

2.295. Study identifies proteins involved in the effectiveness of immunotherapy against blood cancer

  • 2 months ago schedule
  • medicalxpress.com language

A study conducted by researchers at the Center for Cell-Based Therapy (CTC) highlights key proteins and signaling pathways involved in the efficacy of immunotherapy based on CAR-T cells (lymphocytes modified in the laboratory to fight cancer).

2.296. Cannabis use disorder treatment rates decline 32% over 16 years despite persistent high need, study finds

  • 2 months ago schedule
  • medicalxpress.com language

As cannabis becomes more potent and widely used in the United States—especially among young adults—concerns about cannabis use disorder are growing. More than 16 million Americans meet the criteria, yet most never receive treatment.

2.297. Study finds daily cup of beans boosts heart and metabolic health

  • 2 months ago schedule
  • medicalxpress.com language

A new study suggests that regularly eating a cup of beans a day may offer measurable benefits for heart and metabolic health. Incorporating beans into daily diets could serve as a simple, cost-effective way to reduce the risk of chronic diseases.

2.298. Dancing to the dopamine reward threshold: How long-term addiction shifts music perception

  • 2 months ago schedule
  • medicalxpress.com language

Research led by Aarhus University in Denmark reports that individuals with substance use disorders experience a heightened urge to move in response to music with complex rhythms and harmonies.

2.299. Updated data from Phase I study of antibody-drug conjugate EBC-129 released

  • 2 months ago schedule
  • medicalxpress.com language

The Experimental Drug Development Center (EDDC), Singapore's national platform for drug discovery and development, has announced the presentation of updated clinical data for the ongoing Phase I trial for EBC-129 at the 2025 Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago.

2.300. Multiple testing for infectious diseases key to cutting onward transmission, study indicates

  • 2 months ago schedule
  • medicalxpress.com language

Routine testing for multiple infectious diseases among migrants will benefit health care systems by identifying key infections earlier, a new study finds.

2.301. Being in nature can help people with chronic back pain manage their condition, research shows

  • 2 months ago schedule
  • medicalxpress.com language

Spending time in or around nature can provide people suffering from chronic lower back pain with a degree of escapism that helps them better manage their physical discomfort, a new study has shown.

2.302. APA calls for guardrails, education, to protect adolescent AI users

  • 2 months ago schedule
  • medicalxpress.com language

The effects of artificial intelligence on adolescents are nuanced and complex, according to a report from the American Psychological Association that calls on developers to prioritize features that protect young people from exploitation, manipulation and the erosion of real-world relationships.

2.303. New mRNA vaccine is more effective and less costly to develop, study finds

  • 2 months ago schedule
  • medicalxpress.com language

A new type of mRNA vaccine is more scalable and adaptable to continuously evolving viruses such as SARS-CoV-2 and H5N1, according to a study by researchers at the University of Pittsburgh School of Public Health and the Pennsylvania State University. The study was published today in npj Vaccines.

2.304. Project sees a rise in expectant mothers in UK with autoimmune diseases since millennium

  • 2 months ago schedule
  • medicalxpress.com language

Thousands more UK women who are having children have been diagnosed with an autoimmune condition now compared to the beginning of the millennium.

2.305. Gut fungi in very-low-birthweight infants modulate oxygen-induced lung damage, study finds

  • 2 months ago schedule
  • medicalxpress.com language

Extremely preterm newborns who weigh less than 3.3 pounds have immature lungs that often require high levels of ventilation oxygen in the hospital. This contributes to the chronic lung disease bronchopulmonary dysplasia, or BPD, the most common cause of death for these tiny infants. BPD exacts a devastating toll on the immature lung.

2.306. Speech by Dr Hanan Balkhy, WHO Regional Director on the occasion marking Egypt achieving ...

  • 2 months ago schedule
  • emro.who.int language

02 June 2025 Your Excellency, Dr Khaled Abdel Ghaffar, Minister of Health and Population of Egypt, Distinguished officials, Representatives of the Egyptian Vaccine Manufacturers Alliance, Colleagues and Partners, On behalf of the World Health Organization, I extend my warmest congratulations to Egypt for becoming the first country in the Eastern Mediterranean Region to achieve the regional target for hepatitis B control, as set by the Regional Committee Resolution EM/RC56/R.5 (2009). This recognition follows a rigorous review led by the independent Regional Validation Committee (RVC). Based on robust and verifiable data, the RVC concluded that Egypt has indeed met the regional target, supported by the following key indicators: Hepatitis B surface antigen (HBsAg) prevalence among children aged 5 years and older is below 1 per cent; Third-dose hepatitis B vaccine coverage maintained at 90 per cent or higher for over a decade; And birth dose coverage has exceeded 90 per cent for at least five years. These achievements are a testament to your leadership, sustained investment, and steadfast commitment to public health. I commend Your Excellency, the Ministry of Health and Population, and the dedicated teams driving Egypt’s national immunization and hepatitis control programmes. Egypt’s success represents not only a national achievement, but a regional milestone—a powerful example of what is possible when science, policy, and public trust align. Through your strong Expanded Programme on Immunization, you have significantly reduced vaccine-preventable diseases, improved child survival, and strengthened health systems—culminating in the elimination of measles and rubella. WHO stands ready to support you in introducing additional life-saving vaccines to protect against rotavirus, human papillomavirus, Read more...

2.307. Eating healthier can protect aging brain

  • 2 months ago schedule
  • medicalxpress.com language

It's never too late to start eating right as a means of protecting your brain health, a new study says.

2.308. Antibody-drug conjugate shows promising safety and response rates for patients with rare blood cancer

  • 2 months ago schedule
  • medicalxpress.com language

The first-in-class antibody-drug conjugate (ADC) pivekimab sunirine (PVEK) demonstrated promising efficacy and high response rates for patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN), according to data from a Phase I/II study led by researchers from The University of Texas MD Anderson Cancer Center.

2.309. ASCO: Vepdegestrant ups survival in ER+, HER2− advanced breast cancer with ESR1 mutations

  • 2 months ago schedule
  • medicalxpress.com language

For patients with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer, the oral proteolysis-targeting chimera ER degrader, vepdegestrant, leads to significantly longer progression-free survival in patients with ESR1 mutations, according to a study published online May 31 in the New England Journal of Medicine. The research was presented to coincide with the annual meeting of the American Society of Clinical Oncology, held from May 31 to June 4 in Chicago.

2.310. Study: Pre-operative THP leads to pCR in 64% of early-stage HER2+ ER- breast cancer patients

  • 2 months ago schedule
  • medicalxpress.com language

Patients with Stage II and III (early-stage) HER2+ breast cancer usually undergo preoperative therapy with multi-agent chemotherapy in combination with anti-HER2 antibodies, followed by surgery. A less intensive, reduced chemotherapy treatment approach is currently being evaluated in the CompassHER2 pCR trial by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN).

2.311. FDA issues highest alert over tomato recall in 3 southern states

  • 2 months ago schedule
  • medicalxpress.com language

Salmonella-tainted tomatoes in three southern states could cause severe illness or even death, the U.S. Food and Drug Administration (FDA) warns.

Cookie Policy

We use cookies and similar technologies to help the site provide a better user experience. By using the website you agree to our Cookie Policy, Terms of Use and Privacy Policy.